Success Stories: EB1A Approval for a Postdoctoral Research Associate in the field of Nanotechnology and Nanomedicine in 7 days
Client’s Testimonial:
I really appreciate all your and your other attorneys' and associates' help in the process. I don't think it could have been any smoother than this. I'd be more than happy to recommend you on various platforms, not just on LinkedIn. I have been meeting with many more people who would be going for an EB1a route and I would definitely be directing them to you.
On August 12th, 2013 we received another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Research Associate in the field of Nanotechnology and Nanomedicine (Approval Notice)
General Field: Nanotechnology and Nanomedicine Position at the Time of Case Filing: Postdoctoral Research Associate National Origin: India Service Center: Texas Service Center (TSC) State Residing at the Time of Filing: North Carolina Approval Notice Date: August 12, 2013 Processing Time: 7 days (Premium Processing Service requested)
Case Summary:
The client in this case was a postdoctoral research associate in the field of nanotechnology and nanomedicine. His work had primarily focused on developing novel nanoparticles for the delivery and controlled release of chemo- and radio-sensitizer for cancer treatment. His work had resulted in at least 13 peer-reviewed scientific articles and a book chapter. At the time that his case was filed, his publications had accumulated at least 217 citations, clearly demonstrating that he had influenced his field and garnered international acclaim. In addition, he had had applied his considerable expertise in nanotechnology and nanomedicine as a reviewer of 17 manuscripts for publication. Of his accomplishments, one of his independent recommenders remarked, “The results of [client’s] work have strong implications in the field of biomedical nanotechnology, since peptide based nanoparticle formulations can be engineered to have specific therapeutic effects. Such particles are expected to significantly impact future methods of health care; however, scientists first need to have a complete understanding of the complex interactions between individual amino acids (the building blocks of peptides) and the surfaces of nanoparticles. This is specifically what [client] has addressed in his research, placing himself among the top experts internationally with an understanding of small molecule interactions and peptide-mediated nanoparticle synthesis.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of nanotechnology and nanomedicine, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 7 days.